Press release
What Is Driving the US Interventional Cardiology Market Size Toward USD 10.81 Billion by 2033?
US Interventional Cardiology Market Size
According to DataM Intelligence, the US interventional cardiology market reached USD 6.37 billion in 2024 and is expected to reach USD 10.81 billion by 2033, growing at a CAGR of 6.1% during 2025-2033. The market covers minimally invasive approaches used to diagnose and treat cardiovascular conditions through devices such as stents, balloons, guidewires, catheters, closure devices, atherectomy systems, thrombectomy systems and imaging technologies.
Interventional cardiology is increasingly important as healthcare providers favor procedures that can treat coronary and structural heart conditions without the extended recovery associated with open-heart surgery. The growing use of percutaneous interventions, improvements in device technologies and increasing demand for advanced imaging are supporting market expansion across hospitals, catheterization laboratories and ambulatory surgical centers.
Request Exclusive Sample (Top Performing Strategies (Next 5 years)): https://www.datamintelligence.com/download-sample/us-interventional-cardiology-market?indhu
Recent Developments
• In April 2026, Abbott received U.S. FDA clearance for its next-generation Ultreon 3.0 coronary imaging platform. The AI-powered intravascular ultrasound system combines advanced imaging and software capabilities to support coronary artery assessment and treatment, reinforcing the shift toward imaging-guided interventional procedures.
• In March 2026, Boston Scientific launched its iCross Coronary Imaging Catheter in the U.S. The intravascular ultrasound catheter is designed to improve deliverability and visualization of coronary arteries, supporting more precise decision-making during complex interventional cardiology procedures.
• In March 2026, SCAI highlighted results from the PRO-TAVI trial, which found that deferring PCI in selected patients undergoing TAVR was non-inferior to routine PCI and resulted in lower major bleeding. The findings could influence how interventional cardiologists approach coronary revascularization around transcatheter valve procedures.
• In August 2025, Medtronic received U.S. FDA approval for an expanded Redo-TAVR indication for its Evolut TAVR system. The expanded indication strengthens the role of transcatheter valve technologies in patients requiring repeat valve intervention and supports continued innovation in structural heart procedures.
Key Trends in US Interventional Cardiology Market
Rising Structural Heart Disease Interventions Strengthen Market Adoption
The shift from surgical to percutaneous procedures for severe aortic stenosis and mitral regurgitation is supporting demand for interventional cardiology technologies. Improved patient selection, procedural outcomes, and shorter recovery times are encouraging greater use of transcatheter approaches. The aging population and rising prevalence of valvular heart diseases are further strengthening opportunities for structural heart interventions.
Advanced Imaging Technologies Improve Procedural Guidance
The increasing integration of 3D echocardiography, optical coherence tomography (OCT), and intravascular ultrasound (IVUS) is improving visualization and procedural decision-making. Advanced imaging enables physicians to assess cardiovascular structures in greater detail and supports treatment planning and guidance during complex interventions. These capabilities are contributing to greater precision across structural and coronary heart procedures.
Growing Demand for Advanced Stent Technologies
Stents remain a major product category due to the widespread prevalence of coronary artery disease and the established role of percutaneous coronary intervention. Drug-eluting stents, bioabsorbable stents, and improved bare-metal stents have expanded treatment options and improved device performance. Continued product innovation and updated clinical recommendations are supporting demand for newer-generation stent technologies.
US Interventional Cardiology Market Segmentation
By Type
The market covers Stents, Balloons, Guidewires, Closure Devices, Catheters, Atherectomy Systems, Thrombectomy Systems, Imaging Systems, Chronic Total Occlusion Systems (CTO), and Others. Stents represent an important segment because coronary artery disease creates sustained demand for devices used during percutaneous coronary intervention. Advanced imaging, catheter technologies, and specialized systems are also expanding opportunities across increasingly complex cardiovascular procedures.
By End-User
The market is segmented into Hospitals, Ambulatory Surgical Centers, CATH Labs, and Others. Hospitals and CATH labs remain important settings because they provide specialized infrastructure, cardiovascular specialists, imaging systems, and equipment required for complex interventional procedures. Ambulatory surgical centers also provide opportunities as minimally invasive procedures increasingly support shorter stays and efficient treatment pathways.
Get 20% complimentary customization within the report: https://www.datamintelligence.com/customize/us-interventional-cardiology-market?indhu
US Interventional Cardiology Market Regional Analysis
United States
The US represents the geographic focus of this market, supported by a sophisticated cardiovascular healthcare infrastructure, widespread adoption of minimally invasive procedures, advanced catheterization laboratories, and strong demand for innovative cardiovascular devices. The country's established medical device industry and continued development of structural heart interventions further support market expansion.
US Interventional Cardiology Market Competitive Landscape
The US interventional cardiology market features major medical device companies competing through cardiovascular product development, advanced stent technologies, catheter-based systems, imaging solutions, structural heart devices, and specialized intervention technologies. Competition is increasingly shaped by product performance, procedural precision, clinical outcomes, technology innovation, and the ability to address complex cardiovascular conditions through minimally invasive approaches.
Key Players
• Medtronic PLC
• Boston Scientific Corporation
• Abbott Laboratories
• TERUMO CORPORATION
• Koninklijke Philips N.V.
Company Profiles
Medtronic PLC
Medtronic develops cardiovascular and minimally invasive medical technologies across coronary and structural heart applications. Its portfolio includes products supporting catheter-based interventions, stent procedures, and other cardiovascular treatments.
Boston Scientific Corporation
Boston Scientific provides interventional cardiology technologies for coronary and structural heart procedures. Its portfolio covers solutions for percutaneous coronary intervention and complex cardiovascular conditions.
Abbott Laboratories
Abbott develops cardiovascular technologies spanning coronary intervention and structural heart applications. Its portfolio includes stent systems and other devices designed to support minimally invasive cardiovascular procedures.
TERUMO CORPORATION
Terumo develops catheter-based technologies and cardiovascular intervention products for minimally invasive procedures. Its solutions support coronary and vascular interventions across a range of clinical applications.
Buy Now
Purchase This Exclusive Report: https://www.datamintelligence.com/buy-now-page?report=us-interventional-cardiology-market?indhu
Additional Benefits:
• Get Interactive Dashboard Access (With No Additional Cost)
• Three months of analyst support to answer queries related to the report.
Conclusion
The US interventional cardiology market is expanding as healthcare providers increasingly adopt minimally invasive approaches for coronary and structural heart conditions. Rising structural heart interventions, demand for advanced stents, greater use of catheter-based procedures, and improvements in imaging technologies are creating sustained opportunities for cardiovascular device manufacturers.
Future market growth will depend on continued innovation in stents, catheters, imaging systems, structural heart devices, and specialized intervention technologies. Companies capable of improving procedural efficiency, clinical outcomes, and minimally invasive treatment capabilities are positioned to benefit as the market progresses toward US$10.81 billion by 2033.
Frequently Asked Questions
• What is the projected CAGR of the US Interventional Cardiology Market?
The US interventional cardiology market is projected to grow at a 6.1% CAGR during 2025-2033.
• What will be the US interventional cardiology market size by 2033?
The US interventional cardiology market is expected to reach approximately US$10.81 billion by 2033.
• Which segment is expected to dominate the US Interventional Cardiology Market?
Stents are expected to hold the highest market share within the type segment.
Request for 2 Days FREE Dashboard Access: https://www.datamintelligence.com/reports-subscription
☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us:
Sai Kiran
Business Development Manager
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, Lalitha Nagar, Habsiguda,
Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com
About Us :
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release What Is Driving the US Interventional Cardiology Market Size Toward USD 10.81 Billion by 2033? here
News-ID: 4614125 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Can Sovereign AI Cloud Reach USD 1,567 Billion by 2035 as Nations Race to Contro …
According to DataM Intelligence, the global sovereign AI cloud market reached approximately USD 149.57 billion in 2025 and is projected to reach USD 1,567 billion by 2035, expanding at a CAGR of 26.5% during 2026-2035. The market is being driven by increasing investments in national AI infrastructure, growing demand for domestic GPU computing, stricter data-sovereignty requirements, localized foundation-model development, and government-backed AI programs.
Sovereign AI cloud is evolving beyond traditional…
Why Is the Tuberculosis Drug Market Heading Toward USD 3.78 Billion by 2033 as D …
According to DataM Intelligence, the global tuberculosis drug market size is estimated at approximately USD 2.70 billion in 2026 and is projected to reach USD 3.78 billion by 2033, expanding at a CAGR of 4.9% during 2026-2033. The market is being supported by the continued global burden of tuberculosis, growing demand for treatment of multidrug-resistant TB, improvements in diagnosis and treatment coverage, and the development of shorter, all-oral therapeutic regimens.…
Physiotherapy Equipment Market to Reach US$36.19 Billion by 2033, Driven by Risi …
The global physiotherapy equipment market reached USD 21.67 billion in 2025 and is projected to reach USD 36.19 billion by 2033, growing at a CAGR of 6.6% during the forecast period 2026-2033. The market is gaining momentum as the rising prevalence of musculoskeletal disorders, sports injuries, neurological conditions, and age-related mobility problems increases demand for rehabilitation and physical therapy services. Growing adoption of advanced rehabilitation technologies, combined with expanding healthcare…
Diabetic Macular Edema Market to Reach US$8.22 Billion by 2035, Driven by Rising …
The global Diabetic Macular Edema (DME) market reached USD 5.15 billion in 2025 and is expected to reach USD 8.22 billion by 2035, growing at a CAGR of 4.8% during the forecast period 2026-2035. The market is gaining momentum as the rising prevalence of diabetes, increasing incidence of diabetic retinopathy, growing awareness of vision-threatening complications, and improvements in ophthalmic diagnosis continue to drive demand for DME treatments. Advances in anti-VEGF…
More Releases for Interventional
Argon Medical's SuperCore Advantage In Interventional Oncology: The Driving Engi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Interventional Oncology Devices Market Through 2025?
The market for interventional oncology devices has seen a robust expansion in recent times. Its growth trajectory forecasts a swell from $2.39 billion in 2024 to $2.52 billion in 2025, reflecting a compound annual growth rate…
Neurovascular Devices/Interventional Neurology Market Poised for Growth Amid Adv …
The latest report "Neurovascular Devices/Interventional Neurology Market Share, Size, Growth, Opportunities, and Forecast 2024-2032" by Market Insights delivers a thorough analysis of the industry, encompassing market insights. It also covers competitor and regional analysis, along with recent advancements in the market. crucial factors boosting demand include a lesser focus on enhancing the seeker experience, managing large aspirant pools effectively, and using data analytics to optimize reclamation strategies. The report presents…
Global Interventional Radiology Market Size & Trends
According to a new market research report published by Global Market Estimates, the global interventional radiology market is projected to grow at a CAGR of 5.4% from 2023 to 2028.
The primary factors propelling the market growth are the increasing demand for minimally invasive procedures and the rising prevalence of chronic diseases such as heart disease, asthma, and others.
Browse 147 Market Data Tables and 115 Figures spread through 163 Pages and…
Interventional X-Ray Contrast Systems Market - Leading the way in high-quality i …
Newark, New Castle, USA: The "Interventional X-Ray Contrast Systems Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Interventional X-Ray Contrast Systems Market: https://www.growthplusreports.com/report/interventional-xray-contrast-systems-market/8613
This latest report researches the…
Interventional Radiology Drainage Procedures Market - Advanced Interventional Ra …
Newark, New Castle, USA: The "Interventional Radiology Drainage Procedures Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Interventional Radiology Drainage Procedures Market: https://www.growthplusreports.com/report/interventional-radiology-drainage-procedures-market/8596
This latest report researches the…
Interventional Oncology Market By Top Players -
Global Interventional Oncology Market Analysis
According to Verified Market Research, the Global Interventional Oncology Market was valued at USD 1.78 Billion in 2018 and is projected to grow at a CAGR of 6.83% to reach USD 2.96 Billion by 2026, over the forecast period.
What is Interventional Oncology?
Interventional oncology deals with the diagnosis and treatment of cancer using minimally invasive procedures that are performed under image guidance. Interventional oncology is used to…
